The software sector has been on a wild ride. After tumbling more than 37% from its September 2025 peak to its April lows on ...

Your dashboard is green. The suite has passed, coverage looks healthy and leadership assumes the release is safe. But a passing test suite may be misleading. Even with a green dashboard, it's unclear ...

Dubbed Project Jailbreak, the effort is part of the Army’s first hackathon to integrate its many proprietary software ...

Explore MITRE ATT&CK for Cloud, the key cloud tactics and techniques, and how cloud detection and response (CDR) fits into ...

SO WE HAVE TO BE VERY CAREFUL. DROUGHT IS NOTHING TO MESS WITH. OKAY. THAT SAID THIS MORNING IT’S A COUPLE OF CLOUDS OVER TOP OF US. WE DO HAVE A HOLIDAY WEEKEND AHEAD OF US AND WE ARE WATCHING THE ...

Software stocks outperformed chip stocks Monday afternoon, hinting at a possible rotation after semiconductors outpaced software shares for much of the year. The iShares Expanded Tech-Software Sector ...

A code migration agent finishes its run, and the pipeline looks green. But several pieces were never compiled — and it took days to catch. That's not a model failure; that's an agent deciding it was ...

ALBANY, NY (WRGB)- As state budget tensions continue, Medicaid patients and cancer advocates are raising concerns that access to biomarker testing could be narrowed, potentially affecting how quickly ...

Abstract: Software unit testing is a critical verification step to ensure the correctness and reliability of software. However, manual writing of test cases is a time-consuming and error-prone process ...

Anthropic PBC announced the launch of Claude Security in public beta mode today to help cybersecurity teams scan their codebases for vulnerabilities and generate patches. Part of Claude Enterprise, ...

Anthropic caused a stir among developers with what appeared to be a surprise change to its pricing plan: The company signaled that Claude Code, the popular agentic development tool, would no longer be ...

In an era where targeted therapies and immunotherapy are reshaping first-line treatment, the stakes of getting the workup right—and getting it right the first time—have never been higher. This ...